Wed, 15 Feb 2017
Live Webinar Date/Time:
Wednesday, February 15, 2017, 12:30 – 13:30 ET
Dr. Subrata Chakrabarti
Chair, Department of Pathology and Laboratory Medicine at Western University and Chief of Pathology and Laboratory Medicine at London Health Sciences Centre & St. Joseph's Health Care, London, Ontario, Canada.
Lysosomal Acid Lipase Deficiency (LAL-D) is an autosomal recessive lysosomal storage disorder [previously known as Wolman Disease (infants) and Cholesteryl Ester Storage Disease (children and adults)]. In pediatric and adult patients, nearly 50% progress to fibrosis, cirrhosis or liver transplant within 3 years of onset of symptoms.
- Overview of Lysosomal Acid Lipase Deficiency (LAL-D)
Distinguishing LAL-D from other conditions
- Differential diagnosis
- Common histologic features
- Evaluation of steatosis: microvesicular, macrovesicular, and mixed
- Important role of the pathologist in suspicion of LAL-D
At the end of this presentation the attendees will be able to:
- Describe the epidemiological and clinical features of Lysosomal Acid Lipase Deficiency(LAL-D)
- Describe the genetic abnormalities in LAL-D
- Describe the pathogenesis of liver damage in LAL-D
- Describe the histologic features of LAL-D
- Describe the role of Pathologist in the management of LAL-D
To register, please visit CLFLiverEducation.ca/lal-d.
Target audience: Healthcare professionals
We look forward to your participation. If you have any questions, please contact Karen Seto at email@example.com or 1-800-563-5483 ext. 4939.